These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32205821)

  • 1. The Feasibility, Tolerability, Safety, and Accuracy of Low-radiation Dynamic Computed Tomography Myocardial Perfusion Imaging With Regadenoson Compared With Single-photon Emission Computed Tomography.
    van Assen M; Duguay TM; Litwin SE; Bayer RR; Nance JW; Suranyi P; De Cecco CN; Varga-Szemes A; Jacobs BE; Johnson AA; Tesche C; Schoepf UJ
    J Thorac Imaging; 2021 Nov; 36(6):345-352. PubMed ID: 32205821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, multicenter, multivendor study of myocardial perfusion imaging with regadenoson CT perfusion vs single photon emission CT.
    Cury RC; Kitt TM; Feaheny K; Blankstein R; Ghoshhajra BB; Budoff MJ; Leipsic J; Min JK; Akin J; George RT
    J Cardiovasc Comput Tomogr; 2015; 9(2):103-12.e1-2. PubMed ID: 25726411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of combined coronary angiography and adenosine stress myocardial perfusion imaging using 320-detector computed tomography: pilot study.
    Nasis A; Ko BS; Leung MC; Antonis PR; Nandurkar D; Wong DT; Kyi L; Cameron JD; Troupis JM; Meredith IT; Seneviratne SK
    Eur Radiol; 2013 Jul; 23(7):1812-21. PubMed ID: 23430194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
    Patel KK; Al Badarin F; Chan PS; Spertus JA; Courter S; Kennedy KF; Case JA; McGhie AI; Heller GV; Bateman TM
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1821-1831. PubMed ID: 31326480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
    Doukky R; Fughhi I; Campagnoli T; Wassouf M; Ali A
    J Nucl Cardiol; 2017 Feb; 24(1):112-118. PubMed ID: 26582040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.
    Cury RC; Kitt TM; Feaheny K; Akin J; George RT
    J Cardiovasc Comput Tomogr; 2014; 8(1):2-12. PubMed ID: 24314823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging.
    Khan MS; Arif AW; Doukky R
    J Nucl Cardiol; 2022 Apr; 29(2):810-821. PubMed ID: 33034037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Computed Tomographic Angiography and Single-Photon Emission Computed Tomography-Acquired Myocardial Perfusion Imaging for the Diagnosis of Coronary Artery Disease.
    Arbab-Zadeh A; Di Carli MF; Cerci R; George RT; Chen MY; Dewey M; Niinuma H; Vavere AL; Betoko A; Plotkin M; Cox C; Clouse ME; Arai AE; Rochitte CE; Lima JA; Brinker J; Miller JM
    Circ Cardiovasc Imaging; 2015 Oct; 8(10):e003533. PubMed ID: 26467105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regadenoson dynamic computed tomography myocardial perfusion using low-dose protocol for evaluation of the ischemic burden. ULYSSES study.
    Oleksiak A; Kruk M; Pugliese F; Spiewak M; Milosz-Wieczorek B; Marczak M; Demkow M; Kepka C
    J Cardiovasc Comput Tomogr; 2020; 14(5):428-436. PubMed ID: 32029383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung disease.
    Schiopu SRI; Zacherl M; Todica A; Bartenstein P; Milger K; Leuschner G; Munker D; Bauer M; Massberg S; Behr J; Neurohr C; Huber BC; Kneidinger N
    J Nucl Cardiol; 2020 Jun; 27(3):903-911. PubMed ID: 31428982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the extent and severity of myocardial perfusion defects measured by CT coronary angiography and SPECT myocardial perfusion imaging.
    Tamarappoo BK; Dey D; Nakazato R; Shmilovich H; Smith T; Cheng VY; Thomson LE; Hayes SW; Friedman JD; Germano G; Slomka PJ; Berman DS
    JACC Cardiovasc Imaging; 2010 Oct; 3(10):1010-9. PubMed ID: 20947046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of regadenoson with theophylline reversal during dynamic computed tomography perfusion and magnetic resonance imaging in patients with coronary artery disease.
    Oleksiak A; Kruk M; Śpiewak M; Miłosz-Wieczorek B; Marczak M; Demkow M; Kępka C
    Kardiol Pol; 2020 Aug; 78(7-8):709-714. PubMed ID: 32395975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of regadenoson stress myocardial perfusion imaging in patients with left bundle branch block or ventricular paced rhythm.
    Iskander F; Iskander M; Gomez J; Doukky R
    J Nucl Cardiol; 2021 Jun; 28(3):967-977. PubMed ID: 31144225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
    Mahmarian JJ; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Hendel RC; Moye LA; Olmsted AW
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):959-68. PubMed ID: 19679284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing.
    Katz JS; Ruisi M; Giedd KN; Rachko M
    J Nucl Cardiol; 2012 Aug; 19(4):727-34. PubMed ID: 22527801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional diagnostic value of integrated analysis of cardiac CTA and SPECT MPI using the SMARTVis system in patients with suspected coronary artery disease.
    Kirişli HA; Gupta V; Shahzad R; Al Younis I; Dharampal A; Geuns RJ; Scholte AJ; de Graaf MA; Joemai RM; Nieman K; van Vliet L; van Walsum T; Lelieveldt B; Niessen WJ
    J Nucl Med; 2014 Jan; 55(1):50-7. PubMed ID: 24337600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress and rest dynamic myocardial perfusion imaging by evaluation of complete time-attenuation curves with dual-source CT.
    Ho KT; Chua KC; Klotz E; Panknin C
    JACC Cardiovasc Imaging; 2010 Aug; 3(8):811-20. PubMed ID: 20705260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient satisfaction with coronary CT angiography, myocardial CT perfusion, myocardial perfusion MRI, SPECT myocardial perfusion imaging and conventional coronary angiography.
    Feger S; Rief M; Zimmermann E; Richter F; Roehle R; Dewey M; Schönenberger E
    Eur Radiol; 2015 Jul; 25(7):2115-24. PubMed ID: 25764088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of regadenoson SPECT myocardial perfusion imaging: The largest cohort to date.
    Kattoor AJ; Kolkailah AA; Iskander F; Iskander M; Diep L; Khan R; Doukky R
    J Nucl Cardiol; 2021 Dec; 28(6):2799-2807. PubMed ID: 32383079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol.
    Thomas GS; Cullom SJ; Kitt TM; Feaheny KM; Ananthasubramaniam K; Gropler RJ; Jain D; Thompson RC
    J Nucl Cardiol; 2017 Jun; 24(3):788-802. PubMed ID: 28224449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.